El Sherbini has been IDH Group’s CEO since 2012, and before that served as the CEO of Al Mokhtabar between 2004 and 2012. IDH had a network of 546 branch labs as of September 2022. The group recorded revenues of $281 million in 2021 and $143 million in the first nine months of 2022. In August 2022, El Sherbini increased her holdings in the group with 7.3 million additional shares through Hena Holdings to reach 26.71%. In October 2022, IDH and its subsidiary Biolab announced the signing of a joint venture agreement with Fawaz Alhokair’s Izhoor Holding Medical Company to launch Greenfield Diagnostic Venture in Saudi Arabia with investments totaling $19.7 million.